Zeev's Turnips Patch-No Politics (ZEEV)

[hightecheast]

<<despite their receiving clearance (kind of) in the UK>>

... Zeev ... I know you have better vision than I do ... <g> ... but kindly explain where it says "kind of" in LSCP's news release.

From my perspective, this is pretty bullish fundamental news ... no matter who is selling this down in volume.

43.25 close on July 5 to intraday low today of 31.91 is minus 26.2% ... 200 DMA of 31.06 and 50 WMA of 29.48 also look like good buy points ... let em continue to sell it IMO!!!

Ken Wilson
______________________________


UK’S NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
APPROVES PVP PROCEDURE AT NATIONAL HEALTH SERVICE HOSPITALS

Organization Cites Safety, Effectiveness and Efficiency of
PVP Procedure for the Treatment of BPH

SAN JOSE, Calif. (July 19, 2005) – Laserscope (Nasdaq: LSCP), a pioneer in the development and commercialization of medical lasers and advanced fiber-optic delivery devices, announced today that the United Kingdom’s National Institute for Health and Clinical Excellence (NICE) has approved the Photoselective Vaporization of the Prostate (PVP) procedure for the treatment of Benign Prostatic Hyperplasia, or BPH, at National Health Service (NHS) hospitals in England and Wales. The PVP procedure is performed using the GreenLight PV® laser system. NICE approved the PVP procedure after a thorough review of recent clinical studies that showed excellent BPH treatment results using Laserscope’s GreenLight PV® laser system. In its review, NICE determined that the PVP procedure is satisfactorily safe, efficient and effective for the treatment of BPH within the NHS system.

NICE is an independent organization formed in April 1999 to create a single excellence-inpractice body responsible for providing national guidance in the United Kingdom on the
promotion of good health and the prevention and treatment of illness. NICE provides guidance to the National Health Service on public health issues, health technologies, including direction about the use of new and existing medicines, treatments and procedures within the NHS, and clinical practice, including recommendations on the appropriate treatment and care of people with specific diseases and conditions within the NHS. UK’s National Institute For Health And Clinical Excellence Approves PVP Procedure At National Health Service Hospitals.

“We are gratified by NICE’s approval of the PVP procedure for the treatment of BPH,” said Eric Reuter, President and Chief Executive Officer of Laserscope. “Importantly, this approval
removes a prior barrier faced by every NHS hospital for each patient treated with PVP, including an ethical board review and patient consent for a so-called ‘experimental treatment.’
Based on NICE’s review of recent clinical studies, the solicitation of expert opinions and the views of organizations representing both healthcare professionals and patients and caretakers, it was determined that Photoselective Vaporization of the Prostate is a safe and effective procedure to help the many men who are suffering with the symptoms of enlarged prostate.

“Late last year, Kings College in London was granted a prestigious award by the NHS for demonstrating the success of the PVP procedure on an outpatient basis, versus the more
invasive trans-urethral resection of the prostate, or TURP, procedure. The award cited the hospital’s ability to reduce costs and waiting times, while increasing patient satisfaction and experience through utilization of the PVP procedure. The combination of this award and NICE’s recent recommendations should help continue to improve the visibility and credibility of the positive attributes of PVP, not only within the UK’s public healthcare system, but in other two tiered healthcare systems around the world,” continued Mr. Reuter. “Our number one priority has been to ensure that PVP using Laserscope’s GreenLight PV® laser system technology is recognized as the worldwide standard of care for treating BPH, and we believe we are getting closer and closer to achieving that goal every day.”

http://www.laserscope.com/whatsnew/index.html#